The U.S. Senate Health, Education, Labor, and Pensions committee voted on January 12 to move forward with the nomination of DCRI founder Robert Califf, MD, as the next commissioner of the U.S. Food and Drug Administration (FDA).
The vote moves Califf one step closer to assuming the FDA’s highest leadership position. The full Senate must still vote on his nomination; that vote has not yet been scheduled.
President Obama nominated Califf for the position in September of last year. Califf has served as the FDA’s deputy commissioner for medical devices and tobacco since February 2015.
View the November 17, 2015 full senate hearing on the nomination of Dr. Robert Califf to serve as FDA Commissioner.